Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02871258 · ClinicalTrials.gov registry record · NA
MetaNeb® Chest X-ray Study
A NA study, sponsored by Hill-Rom.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02871258 is a NA study that has completed, run by Hill-Rom. The registered enrollment target is 8 participants.
The verdict
NCT02871258, a NA study, has completed, sponsored by Hill-Rom.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
To study objective is to evaluate the impact of use of The MetaNeb® System in clearance of atelectasis, as demonstrated by improvement in chest x-rays. This is a a non-randomized open label study, with all subjects receiving treatment with The MetaNeb® System. Subjects who qualify for enrollment in the study will receive therapy with The MetaNeb® System following the labeled instructions for the device. Details of the treatment including duration and frequency will be defined in treatment procedures.
Interventions
- DEVICE The MetaNeb® System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-08-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02871258
The ClinicalTrials.gov registry entry for NCT02871258 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hill-Rom, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The MetaNeb® System is the first listed.
NCT02871258 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02871258 about?
NCT02871258 is a clinical study titled "MetaNeb® Chest X-ray Study". To study objective is to evaluate the impact of use of The MetaNeb® System in clearance of atelectasis, as demonstrated by improvement in chest x-rays. This is a a non-randomized open label study, with all subjects receiving treatment with The MetaNeb® System. Subjects who qualify for enrollment in ...
What is the current status of trial NCT02871258?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2016-09. Estimated completion is 2017-08-17.
What interventions are being tested in trial NCT02871258?
The interventions under investigation include: The MetaNeb® System (DEVICE).
Who is sponsoring clinical trial NCT02871258?
This trial is sponsored by Hill-Rom, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.